Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sonoma Pharmaceuticals (SNOA) Interest Expenses (2021)

Sonoma Pharmaceuticals (SNOA) has 3 years of Interest Expenses data on record, last reported at $10000.0 in Q4 2012.

  • For Q4 2012, Interest Expenses fell 50.0% year-over-year to $10000.0; the TTM value through Mar 2013 reached $324000.0, down 65.2%, while the annual FY2012 figure was $931000.0, 432.0% up from the prior year.
  • Interest Expenses reached $10000.0 in Q4 2012 per SNOA's latest filing, down from $26000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $718000.0 in Q1 2012 and bottomed at -$10000.0 in Q4 2010.
  • Average Interest Expenses over 3 years is $130000.0, with a median of $83000.0 recorded in 2010.
  • Peak YoY movement for Interest Expenses: surged 1050.0% in 2011, then tumbled 74.26% in 2012.
  • A 3-year view of Interest Expenses shows it stood at -$10000.0 in 2010, then surged by 300.0% to $20000.0 in 2011, then tumbled by 50.0% to $10000.0 in 2012.
  • Per Business Quant database, its latest 3 readings for Interest Expenses were $10000.0 in Q4 2012, $26000.0 in Q3 2012, and $288000.0 in Q2 2012.